Archive for the ‘Business’ Category
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]
June 1, 2011
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Management, Webcast Posted in: Business, El-Hibri, Financial Performance, Healthcare Conference, Investors, fuad el-hibri 
No Comments
Emergent BioSolutions Reports Financial Results for First Quarter 2011
ROCKVILLE, Md., May 05, 2011 (BUSINESS WIRE) — Emergent BioSolutionsInc. (NYSE: EBS) announced В its financial results for the first quarter ended March 31, 2011.
For 1Q 2011, total revenues were $18.5 million as compared to $46.8 million in 2010. In addition, for 1Q 2011 the company recorded a net loss of $21.4 million, or $0.61 per [...]
May 12, 2011
Tags: BARDA, Biothrax, Emergent BioSolutions, fuad el-hibri, Research and development, Revenue Posted in: BioDefense, Biothrax, Business, Chief executive officer, Chief financial officer, Revenue No Comments
Emergent BioSolutions Reports Financial Results for Full Year 2010
2010 revenues of $286.2 million
2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability
2010 cash, investments and accounts receivable balance of $210.4 million
2011 forecast reaffirmed: total revenues of $320 to $340 million and net income of $35 to $45 million
Emergent BioSolutions Inc. (NYSE: EBS) announced on 10 March its [...]
April 13, 2011
Tags: Anthrax vaccines, Biothrax, Business, Chief financial officer, Emergent BioSolutions, Financial Results Posted in: Board of Directors, Business, Chief executive officer, Emergent BioSolutions, Financial Results, fuad el-hibri No Comments
CEO took roundabout path to Emergent
By Marjorie Censer
Monday, January 3, 2011
Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador.
But getting started in his current position as chief executive of Rockville-based pharmaceutical company Emergent BioSolutions took [...]
January 7, 2011
Tags: Chief executive officer, Department of Health and Human Services, El-Hibri, Emergent BioSolutions Inc., entrepreneur, Rockville Posted in: Biosolutions, Business, CEO, Department of Health and Human Services, El-Hibri, Emergent BioSolutions, Research and development, Trubion Pharmaceuticals, Yale University, fuad, fuad el-hibri No Comments
Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals
ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion’s Seattle headquarters on October 28, 2010. The acquisition [...]
November 3, 2010
Tags: Chief executive officer, Emergent BioSolutions, fuad el-hibri, Seattle, Trubion Pharmaceuticals Posted in: Business, Emergent BioSolutions, Seattle, Trubion Pharmaceuticals, fuad el-hibri No Comments
Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars
ROCKVILLE, Md., Aug 24, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today hosted “Looking Beyond the Bench,” a symposium organized for doctoral students enrolled in the NIH-Oxford-Cambridge Scholars Program. The symposium featured Emergent executives, who, based on their extensive experience in the biopharmaceutical industry, [...]
August 30, 2010
Tags: Anthrax vaccines, BioSolutions Inc, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, fuad el-hibri, Infectious disease, Scholars Program Posted in: Anthrax vaccines, Biosolutions, Business, El-Hibri Peace Education Prize, Emergent BioSolutions, Infectious disease, Scholars Program, fuad el-hibri No Comments
Emergent BioSolutions to Participate in June 2010 Investor Conferences
Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:
The Jefferies & Company 2010 Global Life Sciences Conference
New [...]
June 7, 2010
Tags: Business, Emergent BioSolutions Inc., fuad el-hibri, Healthcare Conference, Jefferies & Company, United States., Webcast Posted in: Business, Emergent BioSolutions, Health Care, Healthcare Conference, fuad el-hibri No Comments
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
March 15, 2010
Tags: Business, Chief executive officer, Emergent BioSolutions, fuad el-hibri, Leadership, Maryland Posted in: Biosolutions, Business, Emergent BioSolutions, Management No Comments